ID: ALA5268413

Max Phase: Preclinical

Molecular Formula: C17H17N3O

Molecular Weight: 279.34

Associated Items:

Representations

Canonical SMILES:  NCc1ccc(Cn2ccc3cc(C(N)=O)ccc32)cc1

Standard InChI:  InChI=1S/C17H17N3O/c18-10-12-1-3-13(4-2-12)11-20-8-7-14-9-15(17(19)21)5-6-16(14)20/h1-9H,10-11,18H2,(H2,19,21)

Standard InChI Key:  GFPWNKIPYDKLPA-UHFFFAOYSA-N

Associated Targets(non-human)

tRNA (guanine-N(1)-)-methyltransferase 44 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 279.34Molecular Weight (Monoisotopic): 279.1372AlogP: 2.25#Rotatable Bonds: 4
Polar Surface Area: 74.04Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.31CX LogP: 2.00CX LogD: 0.11
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.77Np Likeness Score: -1.07

References

1. Wilkinson AJ, Ooi N, Finlayson J, Lee VE, Lyth D, Maskew KS, Newman R, Orr D, Ansell K, Birchall K, Canning P, Coombs P, Fusani L, McIver E, Pisco J, Ireland PM, Jenkins C, Norville IH, Southern SJ, Cowan R, Hall G, Kettleborough C, Savage VJ, Cooper IR..  (2023)  Evaluating the druggability of TrmD, a potential antibacterial target, through design and microbiological profiling of a series of potent TrmD inhibitors.,  90  [PMID:37187252] [10.1016/j.bmcl.2023.129331]

Source